Report cover image

Biosimilars: Global Market, Trends and Competitor Analysis

Publisher Kalorama Information
Published Nov 14, 2017
Length 214 Pages
SKU # KLI15532315

Description

Biosimilars: Global Market, Trends and Competitor Analysis

Biosimilars: Global Market, Trends, and Competitor Analysis is a detailed analysis both of the market for biosimilars and for the market effects on pharmaceutical markets. The report provides a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, rest of Europe, Russia, Japan, India, China, South Korea, Australia, Brazil, Mexico, Turkey, Iran, Canada and rest of world biosimilars market to 2022.

The report looks at the biosimilar market by application, including the autoimmune disease, blood disorder, cancer, diabetes and growth hormone deficiency biosimilar markets from 2006 to 2022. Biosimilars: Global Market, Trends, and Competitor Analysis also breaks down the biosimilars market by product type, including the following segments: biosimilar recombinant non-glycosylated protein market; biosimilar recombinant glycosylated protein market; monoclonal antibodies: biosimilar product sales; and biosimilar recombinant peptide and other product market from 2017 to 2022.

Biosimilars: Global Market, Trends, and Competitor Analysis provides a complete competitor analysis for 2017, by percentage of global market share. Eli Lilly, Pfizer and Sandoz are among the companies participating in this unique market and are profiled in the report.

The report draws six main market conclusions that involve patent protection, pricing, market participants, emerging markets, evolving market strategies and education.

Table of Contents

214 Pages
    • Overview
    • Scope and Methodology
    • Size and Growth of the Market
    • Biosimilars Overview
    • Biopharmaceutical Industry and Approval Process
    • Genetic Engineering
    • Patent Approval
    • Regulations for Biopharmaceuticals
    • History of the Prescription Generic Pharmaceuticals Industry
    • History of the Generic Approval Process
    • Regulation of Prescription Generic Pharmaceuticals
    • Biopharmaceuticals
    • Select Marketed Biologics with Expired Patents
    • Select Marketed Biologics with Active Patents
    • Biosimilar Market by Region
    • Europe and Biosimilars
    • United States and Biosimilars
    • Rest of World and Biosimilars
    • Overview
    • Total Market Size and Forecast
    • Several blockbuster biologics are losing patent protection
    • Cost and discount pricing
    • New market participants
    • Different strategies for emerging markets
    • Evolving biosimilar strategies
    • Education key to success of biosimilars
    • 3SBio, Inc
    • Amega Biotech
    • Amgen Biosimilars
    • Apotex, Inc.
    • AXXO GmbH
    • Beijing Four Rings Biopharmaceutical Co Ltd.
    • Biocad
    • Biocon Ltd
    • Biogen Inc.
    • BioGenomics Ltd.
    • BioPartners GmbH
    • Biosidus S.A.
    • Bioviz Technologies Pvt. Ltd
    • BioXpress Therapeutics S.A.
    • Boehringer Ingelheim GmbH
    • Celltrion, Inc.
    • Chemo Group (Grupo Isud)
    • Coherus BioSciences, Inc
    • DM Bio (Dong-A Pharmaceuticals)
    • Dr. Reddy's Laboratories Limited
    • Gedeon Richter
    • Harvest Moon Pharmaceuticals USA, Inc.
    • Hospira, Inc.
    • Inbiopro Solutions Pvt Ltd
    • Intas Pharmaceuticals Ltd
    • Kyowa Hakko Kirin Co, Ltd
    • LG Chem Ltd.
    • Merck & Company
    • Momenta Pharmaceuticals Inc.
    • Mylan N.V.
    • PFEnex Inc.
    • Pfizer Biosimilars Inc.
    • Reliance GeneMedix Limited
    • Reliance Life Sciences
    • Samsung Bioepis Co Ltd
    • Sandoz International GmbH
    • SciGen Ltd (Bioton)
    • Stada Arzneimittel AG
    • Teva Pharmaceutical Industries Ltd
    • Zydus Cadila Healthcare Ltd.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us